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Abstract
Background: There is no clear picture regarding the prevalence rates of autism and its comorbidities among Iranian children and 
adolescents. The present study aimed to estimate these rates as part of a large national population-based study on epidemiology of 
psychiatric disorders in Iranian children and adolescents.
Methods: The total sample consisted of 31 000 children and adolescents between 6 to 18 years of age. The Kiddie Schedule for 
Affective Disorders and Schizophrenia for School-Age Present and Life time version (K-SADS-PL) was used as the diagnostic tool.
Results: The prevalence of autism in the total sample is equal to 0.1% (10 per 10 000), with a 2:1 male-to-female ratio. In total, 
86% of people with autism had at least one comorbid condition. Intellectual disability, epilepsy, enuresis and attention deficit and 
hyperactivity disorder (ADHD) with prevalence rates of 70.3%, 29.7%, 27% and 21.62%, respectively, were the most prevalent 
comorbid conditions in people with autism. Maternal personality disorders were also shown to be associated with increasing risk 
of autism.
Conclusion: The present study shows high prevalence rates for autism and its comorbid conditions among Iranian children and 
adolescents. It also reveals that there is a relationship between some maternal psychiatric disorders and the risk of autism. 
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Introduction
Autism spectrum disorder (ASD) is a severe 
neurodevelopmental disorder characterized by deficits in 
social and communication skills as well as restricted and 
repetitive behaviors.1 Its prevalence has risen dramatically 
in recent years; for example, its prevalence in the United 
States was reported at 0.67% in 2000, 1.47% in 2010 and 
2.58% in 2016.2 Some researchers argue that improvement 
in diagnostic methods and changes in definition have 
contributed to this rise to some extent. Most rigorous 
studies to determine the prevalence of ASD have been 
conducted in developed countries. In Iran, as a low and 
middle-income country, the prevalence rate of autism 
has been investigated in only few studies. The first study 
was published in 2008. In this school-based study, 2000 
school-aged children were randomly selected from typical 
schools in Shiraz. A parent report rating scale based on the 
Diagnostic and Statistical Manual of Mental Disorders-
IV-TR (DSM-IV-TR) criteria of pervasive developmental 
disorders (PDD) symptoms was used. The results showed 
that about 1.9% and 0.5% of the sample were screened 
positive for probable autistic disorder and probable 
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Asperger’s disorder, respectively.3 In another study, the 
obtained data from the Iranian national screening program 
for special needs was explored to estimate the prevalence of 
autism among five-year-old children. This study showed 
the prevalence of typical autism at 6.26 per 10 000. The 
results of this study were limited to only five-year-old 
children and typical autism.4
Comorbid psychiatric and medical conditions 
are common in people with ASD and make it more 
complicated to manage5-8 and drastically influence the 
progress and outcomes of this disorder.9 Structured 
diagnostic interviews have shown that more than 70% of 
children with ASD have at least one comorbid disorder.10 
Intellectual disability, epilepsy and ADHD are the most 
common comorbidities in people with ASD.11 It has 
been reported that age and sex have some impact on the 
prevalence rate of comorbidities; ADHD is more common 
among males11 and epilepsy is more common among 
females.12,13 Also, it has been reported that the prevalence 
of schizophrenia increased with age. 
In Iran, there is only one published study on comorbid 
conditions among children with autism. This study had a 
small sample size (n = 91) and only included children from 
five special schools for autistic students located in Tehran, 
the capital of Iran.14 Nevertheless, this study showed that 
72% of participants had at least one comorbid condition, 
and attention‐deficit/hyperactivity disorder and epileptic 
disorders were the most prevalent comorbid conditions 
among students with autism.
Also, it has been shown that the relatives of people 
with autism, especially their parents, are at higher risk of 
experiencing psychiatric disorders.15,16 For example, studies 
using semi-structured psychiatric interviews reveal that 20 
to 37% of the relatives of people with autism have had a life 
time history of major depression.17 A recent population-
based study also showed that psychiatric disorders are more 
common in parents of children with autism; higher risk of 
autism among children was associated with diagnosis of 
schizophrenia in both parents, depression in mothers, and 
neurotic and personality disorder and other nonpsychotic 
disorders.18 Most researchers believe that this association 
means that there are common genetic/familial factors 
between autism and other psychiatric disorders and also 
that genetic factors underlie autism.16
In the current study, using data retrieved from a large-
sample population-based study,19 we aimed to estimate 
the prevalence of autism, its comorbidities and the role of 
parental psychiatric disorders in increased risk of autism 
among Iranian children and adolescents.
Materials and Methods
Participants and Sampling
This study is part of a large-sample national population-
based study on the epidemiology of psychiatric disorders 
among Iranian children and adolescents. It was a cross-
sectional study on children and adolescents aged 6 to 
18 years and was implemented in all provinces of Iran. 
Assuming a prevalence of psychiatric disorders equal to 
0.3, type one error of 0.05 and accepted error of 0.05, 
the sample size for each province was calculated equal to 
825. We suggested the design effect for cluster sampling 
as 1.2; so, the final sample size in each province increased 
to 990 (1000). The total sample size amounted to 31 000. 
The sample was selected randomly using multistage cluster 
sampling method based on postal codes of houses. Our 
sampling frame was all Iranian citizen aged 6 to 18 years 
who lived in either urban or rural areas in each province. We 
randomly selected 170 clusters of houses in each province 
and each cluster included six children and adolescents 
between 6 to 18 years of age. In sum, we selected about 
1.000 cases from each province, except Tehran, the most 
crowded province of Iran, where we selected 340 clusters 
and around 2000 cases.
Survey analysis was used in the  Stata software and 
clustering was applied but the selection of clusters and 
samples in clusters were random; we expected that the 
samples’ selection probabilities were equal and our results 
confirm. We  were strict in interpreting the results and 
have interpreted the P values above 0.01 and below 0.05 
cautiously.
As mentioned, the number of people who were selected 
as sample for this study was equal in all provinces. However, 
the population of children and adolescence is not equal in 
all provinces; hence, the data were weighted to represent 
the population. We used the population weighting 
adjustment based on the population distribution of 
children and adolescents in each province according to the 
formula below. Stata software was used for all data analysis. 
1 100
1000
Wij
Pij
= ∗
∗
Wij: Weight of individual in each province; 
Pij: Probability of individual selection in their province
More detailed information regarding the methodology 
of the main study has been provided in its published 
protocol.20
Instruments
Demographic data (gender, age, education, parents’ 
education, and economic status) was gathered using a 
questionnaire designed by the investigators.
To identify the children and youth who had symptoms 
of autism, the autism section of the new Kiddie Schedule 
for Affective Disorders and Schizophrenia for School-Age 
Present and Life time version (K-SADS-PL-2009)21 was 
used. To investigate comorbid psychiatric disorders, the 
K-SADS-PL was used.22 Some additional questions were 
used to detect Intellectual Disability and epilepsy.
We also used the Millon Clinical Multiaxial Inventory 
- Third Edition (MCMI-III) to assess parental personality 
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traits and psychopathology.23
All interviews were conducted by trained clinical 
psychologists.
Statistical Analysis
Descriptive statistic indices were used to obtain the 
prevalence data in terms of demographic variables. All the 
statistics on the prevalence of psychiatric disorders are also 
based on the weighted percentages (weighting based on the 
number of provincial samples) as well as crude percentages 
(without weight). We used post stratification weights to 
adjust the survey sample to the underlying population 
demographic structure. The weighted percentages were 
measured based on the population distribution of children 
and adolescents across the provinces according to the 
2017 national census (1 weight was assigned to every one 
million people and the other weights were determined 
accordingly).
Results
Table 1 presents the demographic information of the total 
sample. In total, 49% of the sample were male and 51% 
were female, with an age range of 6 to 18 years. Of our 
participants, 83.3% lived in urban areas and 16.7% lived 
in rural areas (Table 1). 
The prevalence of autism in the total sample was equal to 
0.1% (10/10 000), with a 2:1 male-to-female ratio (Table 
1). As seen in Table 1, there are no significant differences 
in the prevalence of autism based on the demographic 
variables.
As Table 2 and Figure 1 demonstrate, 86% of people 
with autism had at least one comorbid condition. 
Intellectual Disability, epilepsy, enuresis and ADHD with 
prevalence rates of 70.3%, 29.7%, 27% and 21.62%, 
respectively, were the most prevalent comorbid conditions 
among people with autism. There was some effect for sex 
on the rate of comorbid conditions; however, it was not 
statistically significant (see Table 2).
Only mothers of autistic cases filled out the Millon 
inventory. The relationship between mothers’ personality 
disorders and clinical scales and the prevalence of autism 
is presented in Tables 3 and 4. Autism was more prevalent 
among children of mothers who fell in almost all of the 
diagnostic groups, but some of the differences were not 
statistically significant. 
Discussion
As mentioned previously, there is no clear picture regarding 
Table 1. Prevalence of Autism Disorder Based on Demographic Variables in Children and Adolescents
Demographic 
Variables
With Autism Disorder Binary Logistic Regression
Total, No. (%) n (Unweighted %) 95% CI %Weighted  (95% CI) OR 95% CI P Value
Sex
Boy 14567 (49) 22 (0.2) 0.1–0.23 0.23 (0.15–0.35) Base line 
Girl 15170 (51) 15 (0.1) 0.06–0.16 0.11 (0.06–0.2) 0.65 0.34–1.26 0.21
Age group
6–9 10129 (34.1) 11 (0.1) 0.0 6–0.2 0.09 (0.04–0.2) Base line 
10–14 10405 (35) 18 (0.2) 0.11– 0.27 0.29 (0.19–0.45) 1.59 0.75–3.37 0.23
15–18 9203 (30.9) 8 (0.1) 0.05–0.18 0.09 (0.04–0.21) 0.80 0.32–1.99 0.63
Place of 
residence
Urban 24785 (83.3) 30 (0.1) 0.08–0.17 0.17 (0.12–0.25) Base line 
Rural 4952 (16.7) 7 (0.1) 0.07–0.29 0.15 (0.05–0.43) 1.17 0.51-2.66 0.71
Father’s 
education
Illiterate 1290 (4.5) 12 (0.2) 0.04–0.57 0.14 (0.02–0.79) Base line 
Elementary school 4610 (16.1) 6 (0.1) 0.06–0.28 0.23 (0.10–0.50) 0.84 0.17–4.16 0.83
Middle & high school 6383 (22.3) 10 (0.2) 0.09–0.29 0.18 (0.09–0.37) 1.01 0.22–4.62 0.99
Diploma 8340 (29.1) 9 (0.1) 0.06–0.21 0.16 (0.08–0.3) 0.69 0.15–3.22 0.64
Bachelor 6053 (21.1) 7 (0.1) 0.06–0.24 0.08 (0.03–0.23) 0.75 0.15– 3.59 0.71
MSc or higher 1966 (6.9) 2 (0.1) 0.03–0.37 0.39 (0.17–0.91) 0.66 0.09–4.66 0.67
Missing 1095 1
Mother’s 
education
Illiterate 1694 (5.9) 1 (0.1) 0.01–0.34 0.1 (0.02–0.58) Base line 
Elementary school 5466 (18.9) 7 (0.1) 0.06–0.25 0.24 (0.12–0.50) 2.17 0.27–17.66 0.47
Middle & high school 5645 (19.5) 7 (0.1) 0.06–0.25 0.06 (0.02–0.22) 2.10 0.26–17.10 0.49
Diploma 9593 (33.1) 15 (0.2) 0.1–0.26 0.18 (0.01–0.32) 2.65 0.35-20.08 0.34
Bachelor 5555 (19.2) 7 (0.1) 0.06–0.27 .27 (0.15–0.49) 2.14 0.26-17.37 0.48
MSc or higher 986 (3.4) - - - - - -
Missing 798
Father job
Public sector 18443 (64.3) 13 (0.1) 0.08–0.24 0.17 (0.09–0.31) Base line 
Private sector 9270 (32.3) 20 (0.1) 0.07–0.17 0.13 (0.08–0.21) 0.73 0.38–1.55 0.47
Unemployed 989 (3.4) 3 (0.3) 0.1–0.9 0.81 (0.35–1.88) 2.17 0.62–7.61 0.23
Missing 1035 1
Mother job
Public sector 1209 (4.2) 3 (0.1) 0.03–0.29 0.25 (0.11–0.59) Base line 
Private sector 3086 (10.6) - - - - - -
 Housewife 24751 (85.2) 34 (0.1) 0.1 - 0.2 0.17 (0.12–0.25) 1.41 0.43–4.6 0.57
Missing 691
Total 29737 (100) 37 (0.1) 0.09–0.17 0.18 (0.12–0.24)
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Table 2. Rates of Comorbid Psychiatric Disorders in Children and Adolescents with Autism Disorder
Psychiatric Disorders
Total Sex: Male (1), Female (2) Age group: 6–9 (1), 10–14 (2), 15–18 (3)
No. (%) (CI) No. (%) OR (CI) No. (%) OR (CI)
Total disorders
32 (86)
 (72.03–94.9)
1 19 (86.4) 1 baseline 1 8 (80) 1 baseline
2 13 (92.9) 2.05 (.19–21.97)
2 16 (88.9) 2.00 (.24–16.93)
3 7 (86.5) 1.75 (.13–23.70)
Depressive 
1 (2.7)
 (0.5–1.38)
1 1 (4.5) 1 baseline 1 0 1 baseline
2 0 0
2 0 —
3 1 (12.5) —
Anxiety 
disorders
Separation anxiety disorder 5 (13.5) (5.91–27.97)
1 2 (9.1) 1 baseline 1 0 1 baseline
2 3 (20) 2.5 (0.36–17.2)
2 4 (22.2) —
3 1 (12.5) —
Social phobia 7 (19)  (9.5–34.21)
1 5 (23.8) 1 baseline 1 1 (9.1) 1 baseline
2 2 (13.3) 0.49 (0.08–2.97)
2 5 (29.4) 4.17 (0.42–41.78)
3 1 (12.5) 1.43 (0.08–26.89)
Specific phobia 1 (2.7) (0.5–1.38)
1 0 1 baseline 1 0 1 baseline
2 1 (6.7) 0
2 0 —
3 1 (12.5) —
Agoraphobia 1 (2.7) (0.5–1.38)
1 0 1 baseline 1 0 1 baseline
2 1 (6.7) 0
2 0 —
3 1 (12.5) —
Generalized anxiety disorder 5 (13.5) (5.91–27.97)
1 4 (18.2) 1 baseline 1 0 1 baseline
2 1 (7.1) 0.35 (0.03–3.5)
2 3 (16.7) —
3 2 (28.6) —
Obsessive compulsive 
disorder
5 (13.5) (5.91–27.97)
1 3 (13.6) 1 baseline 1 0 1 baseline
2 2 (13.3) 0.97 (14–6.67)
2 2 (11.1) —
3 3 (37.5) —
Total anxiety disorders 10 (27) (15.4–42.98)
1 6 (27.3) 1 baseline 1 1 (9.1) 1 baseline
2 4 (50) 1.39 (0.32–5.89)
2 6 (33.3) 4.91 (0.50–48.62)
3 4 (50) 9 (0.75–108.3)
Behavioral 
Disorders
Attention deficit 
hyperactivity disorder
8 (21.6) (11.39–37.19)
1 7 (33.3) 1 baseline 1 3 (27.3) 1 baseline
2 1 (6.7) 0.14 (0.01–1.32)
2 4 (23.5) 0.82 (0.14–4.66)
3 1 (12.5) 0.38 (0.03–4.55)
Conduct disorder 1 (2.7) (0.5–1.38)
1 1 (4.5) 1 baseline 1 0 1 baseline
2 0 0
2 1 (5.6) —
3 0 —
Oppositional defiant 
disorder
6 (16.2) (7.65–31.14)
1 4 (18.2) 1 baseline 1 1 (9.1) 1 baseline
2 2 (13.3) 0.69 (0.11-4.36)
2 4 (22.2) 2.85 (0.28–29.56)
3 1 (12.5) 1.43 (0.08–26.89)
Tic disorder 3 (8.1) (2.8–21.3)
1 3 (13.6) 1 baseline 1 0 1 baseline
2 0 0
2 3 (16.7) —
3 0 —
Total behavioral disorders 11 (29.7) (17.49–45.78)
1 9 (40.9) 1 baseline 1 3 (27.3) 1 baseline
2 2 (13.3) 0.21 (0.4–1.1)
2 7 (38.9) 1.87 (0.36–9.63)
3 1 (12.5) 0.38 (0.03–4.55)
Intellectual disability 26 (70.3) (54.22–82.51)
1 15 (68.2) 1 baseline 1 6 (54.5) 1 baseline
2 11 (73.3) 1.28 (0.3–5.5)
2 13 (72.2) 2.17 (0.45–10.43)
3 7 (87.5) 5.83 (0.52–64.82)
Epilepsy 11 (29.7) (17.49–45.78)
1 8 (36.4) 1 baseline 1 2 (18.2) 1 baseline
2 3 (20) 0.44 (0.09–2)
2 7 (38.9) 2.86 (0.47–17.35)
3 2 (25) 1.50 (0.16–13.75)
Total neurodevelopmental 
disorders
28 (75.7) (59.9–86.6)
1 17 (77.3) 1 baseline 1 7 (63.6) 1 baseline
2 11 (73.3) 0.8 (0.18–3.6)
2 14 (77.8) 2 (0.38–10.48)
3 7 (87.5) 4 (0.35–45.38)
Elimination 
Disorders
Enuresis 10 (27) (15.4–42.98)
1 7 (31.8) 1 baseline 1 3 (27.3) 1 baseline
2 3 (20) 0.54 (0.11–2.5)
2 5 (27.8) 1.03 (0.19–5.50)
3 2 (25) 0.89 (0.11–7.11)
Encopresis 4 (10.8) (4.28–24.71)
1 2 (9.1) 1 baseline 1 1 (9.1) 1 baseline
2 2 (13.3) 1.53 (0.2–12.3)
2 2 (11.1) 1.25 (0.1–15.65)
3 1 (12.5) 1.43 (0.08–26.9)
Total Elimination Disorders 10 (27) (15.4–42.98)
1 7 (31.8) 1 baseline 1 3 (27.3) 1 baseline
2 3 (20) 0.54 (0.11–2.5)
2 5 (27.8) 1.03 (0.19–5.51)
3 2 (25) 0.89 (0.11–7.11)
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the prevalence of autism and its comorbidities among 
Iranian children and adolescents and the present study is 
the first national population-based study to address these 
issues.
Previous studies have shown heterogeneity in estimated 
prevalence of autism around the world; in a systematic 
review, its median was reported at 62 per 10 000.24 The 
current study has estimated the prevalence of autism 
at 0.1% (or 10 per 10 000) in a large sample of Iranian 
children and adolescents. This rate is close to and in fact 
higher than the previously reported prevalence of typical 
autism in Iran (i.e. 6.26 per 10 000). Like previous studies, 
in this study, the prevalence rate is higher in male subjects 
compared to females (0.1% in females vs. 0.2% in males), 
although the difference is not statistically significant (OR: 
0.65, CI: 0.34–1.26). However, the male-to-female ratio 
reported in this study (2:1) is lower than the results of 
previous studies (i.e. 3:1to 4:1).
Comorbid conditions were common in our sample; 86% 
(CI:72.03–94.9) of participants had at least one comorbid 
condition. Intellectual disability (MR) with 70.3% (CI: 
54.22–82.51) was the most prevalent comorbidity. This 
high rate of MR among our ASD positive cases can explain 
the low prevalence rate of autism in the total sample; it 
seems that we only detected the severe cases of autism. 
Some researchers argue that the prevalence of MR is higher 
in female subjects with autism compared to male subjects; 
we found a similar pattern in our study (OR: 1.28, CI: 
0.3–5.5).
A national survey on 85 248 children and adolescents 
aged between 2-17 years has shown that 8.6% of ASD 
cases had comorbid epilepsy,25 while in our study, this rate 
was found to be 29.7% (CI: 17.49–45.78) of the ASD 
cases. In addition to the high prevalence of MR, this high 
rate of epilepsy compared with other similar studies reveals 
that our detected ASD cases fall in the range of severe 
symptoms.
Previous studies have shown that rates of enuresis in 
ASD cases are 2–16%.26 We found this rate to be 27% 
 1 
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Figure 1. Rate of Comorbid Disorders in Autism Spectrum 
Disorder in Percent.
(CI: 15.4–42.98) in our study. One important factor that 
increases enuresis in people with ASD is the adverse effect 
of medication.26 Given the high prevalence of comorbid 
conditions in our sample, especially MR and epilepsy, 
these people were subject to taking more medications27 
and thus, some proportion of this co-occurring enuresis 
may be due to using medications.
Attention deficit and hyperactivity disorder (ADHD), 
with a prevalence of 21.62%, was the next common 
comorbid psychiatric disorder in our sample of ASD cases. 
This observation is in the range of the findings of previous 
similar studies.27
In our sample of children and adolescents with 
ASD, there were other comorbid conditions, including 
social phobia, oppositional defiant disorder, obsessive 
compulsive disorder, generalized anxiety, separation 
anxiety, encopresis, tic, conduct, agoraphobia, specific 
phobia and depression with prevalence rates of 19%, 
16.2%, 13.5%, 13.5%, 13.5%, 10.8%, 8.1%, 2.7%, 
2.7%, 2.7% and 2.7%, respectively. This large number 
and variety of comorbid conditions should be considered 
in planning therapeutic programs for children with autism. 
These can adversely affect the outcomes of interventions 
and can also complicate the management of the child’s 
behaviors.
Some studies have revealed sex differences in comorbid 
conditions among children with autism. For example, it 
has been shown that ADHD is more common in males 
compared to females.11 Our study also showed these sex 
differences; however, they were not statistically significant. 
For example, ADHD was more prevalent in male 
participants (odds ratio [OR]: 0.14, CI: 0.01–1.32) while 
separation anxiety was more prevalent in females (OR: 2.5, 
CI: 0.36–17.2). We also found some differences between 
age groups (i.e. 6–9, 10–14 and 15–18 years) regarding 
comorbidities. Anxiety disorders (OR: 4.91, CI: 0.50–
48.62, OR: 9, CI: 0.75–108.3) and neurodevelopmental 
disorders (OR: 2, CI: 0.38–10.48, OR: 4, CI: 0.35–45.38) 
were more prevalent in older age groups. This pattern can 
be explained by the fact that people with autism are going 
to be more deprived with increasing age and will feel more 
anxious facing the pressure of increasing social demands. 
Behavioral disorders increased in middle childhood (OR: 
1.87, CI: 0.36–9.63) and then decreased (OR: 0.38, CI: 
0.03–4.55). Importantly, it should be noted that due to the 
small number of ASD cases and wide range of confidence 
intervals, this finding should be considered with caution.
As seen in Tables 3 and 4, maternal personality disorders 
were associated with increasing risk of autism. This 
association was statistically significant among mothers 
who were at risk of schizoid (OR: 5.25, CI:1.25–22.03), 
melancholic (OR: 3.33, CI: 1.28–8.66) and persistent 
depression (OR: 5.12, CI: 1.55–16.85) and also those who 
were diagnosed with schizoid (OR: 21.86, CI: 2.91-164.04) 
and posttraumatic stress disorder (OR: 10.14, CI:1.37–
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75.03). This finding is in line with the results of previous 
studies conducted in other countries. A population-based 
study in Sweden28 reported that schizophrenia was more 
common among both parents of children with autism, in 
comparison to non-autistic children. However, depression 
and personality disorders were more prevalent only among 
mothers of children with autism. Another population-
based study in Finland investigated the relationship 
between parental psychiatric disorders and the risk of ASD 
in children based on its subgroups (i.e. childhood autism, 
Asperger syndrome and PDD-NOS).18 This study showed 
that there was a relationship between increased risk of ASD 
and the presence of maternal and paternal schizophrenia, 
affective disorders, neurotic and personality disorders and 
other nonpsychotic disorders. However, there are some 
differences between maternal and paternal effects among 
ASD subgroups. Paternal schizophrenia, affective disorders, 
and neurotic and personality disorders were associated with 
risk of childhood autism, whereas only maternal affective 
disorders were associated with that risk. Also, Asperger 
syndrome was associated with schizophrenia, affective 
disorders, neurotic and personality disorders and other 
nonpsychotic disorders in mothers and affective disorders, 
neurotic and personality disorders and other nonpsychotic 
disorders in fathers. PDD-NOS was also associated with all 
parental psychiatric disorders. In summary, this observed 
Table 3. Odds Ratios (95% CI) for Children and Adolescents with Autism Disorders Based on Maternal Personality Disorders
Maternal Personality 
Disorders
Diagnostic 
Labels
Children with
Autism disorders, No. (%)
Univariate Multivariate
OR (CI 95%) P Value OR (95% CI) P Value
Clinical pattern 
of personality 
disorders
Schizoid  
No 31 (0.1) Baseline 
At risk 2 (0.6) 5.25 (1.25–22.03) 0.023 4.56 (0.92–22.62) 0.063
Yes 1 (2.4) 21.86 (2.91–164.04) 0.003 18.58 (1.73–20.05) 0.016
Avoidant 
No 33 (0.1) Baseline
At risk 1 (0.4) 3.38 (0.46–24.79) 0.24 1.23 (0.13–11.88) 0.861
Yes 0 — — — —
Melancholic
No 27 (0.1) Baseline
At risk 5 (0.4) 3.33 (1.28–8.66) 0.014 2.66 (0.94–7.58) 0.067
Yes 2 (0.2) 1.54 (0.37–6.49) 0.56 0.69 (1.08–4.469) 0.701
Dependent  
No 34 (0.1) Baseline
At risk 0 — — — —
Yes 0 — — — —
Histrionic 
No 26 (0.1) Baseline
At risk 5 (0.1) 0.95 (0.36–2.48) 0.92 1.11 (0.42–2.93) 0.842
Yes 3 (0.1) 0.80 (0.24–2.63) 0.71 0.94 (0.28–3.19) 0.926
Narcissistic 
No 33 (0.1) Baseline
At risk 1 (0.1) 0.71 (0.1–5.18) 0.73 0.62 (0.08–4.62) 0.640
Yes 0 — — — —
Anti-social
No 34 (0.1) Baseline
At risk 0 — — — —
Yes — — — — —
Sadistic 
No 34 (0.1) Baseline
At risk 0 — — — —
Yes 0 — — — —
Obsessive 
compulsive 
No 24 (0.1) Baseline
At risk 3 (0.1) 1.20 (0.36–3.99) 0.76 1.16 (0.35–3.87) 0.809
Yes 7 (0.1) 1.26 (0.54–2.94) 0.58 1.26 (0.54–2.95) 0.592
Negativistic 
No 31 (0.1) Baseline
At risk 3 (0.3) 2.34 (0.71–7.68) 0.16 1.24 (0.29–5.25) 0.775
Yes 0 — — — —
Masochistic
No 34 (0.1) Baseline
At risk 0 — — — —
Yes 0 — — — —
Severe 
Personality 
Pathology 
scales
Schizotypal
No 33 (0.1) Baseline
At risk 1 (0.6) 5.01 (0.68–36.85) 0.12 2.27 (0.21–24.73) 0.501
Yes 0 — — — —
Borderline
No 34 (0.1) Baseline
At risk 0 — — — —
Yes 0 — — — —
Paranoid
No 34 (0.1) Baseline
At risk 0 — — — —
Yes 0 — — — —
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relationship between parental psychiatric disorders and 
risk of autism is twofold. First, like in previous studies, 
this supports the idea that autism can have a genetic basis 
which is common with other psychiatric disorders to some 
extent; second, it indicates that we should consider the 
presence of psychiatric disorders among autistic families in 
interventional programs.
In summary, based on the results of the present study, 
it may be stated that the estimated prevalence of autism 
among Iranian children and adolescents is 0.1% (10 per 
10 000); however, it seems that this prevalence represents 
cases who have more severe symptoms of autism.
Comorbid psychiatric disorders are common among 
autistic cases. Intellectual Disability, epilepsy, enuresis 
and ADHD are the most prevalent comorbid conditions 
in people with autism. These high rates of comorbid 
conditions should be considered in interventional 
programs.
Our findings also show that there is a relationship 
between some maternal psychiatric disorders and risk of 
autism, which is assumed to reveal a shared genetic basis 
between autism and other psychiatric disorders.
Limitations
The most notable limitation of the present study is that 
based on the data gathering procedure and diagnostic tool, 
the estimated prevalence could not reflect the number 
of all suspected ASD cases among Iranian children and 
adolescents; rather, it only reveals the prevalence of severe 
cases of autism.
As seen in Table 2, the presence of huge confidence limits 
and wide confidence intervals suggests sparse-data bias 
and imprecision.29 This should be noted as an important 
limitation of this study that can influence our findings.
Regarding parental psychiatric disorders, we only had the 
mothers’ data and thus, we could not depict a full picture 
of psychiatric disorders among parents of Iranian children 
with autism. 
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Table 4. Odds Ratios  (%95 CI) for Children and Adolescents with Autism Disorders Based on Maternal Clinical Scale
Mother Personality 
Disorders
Diagnostic 
Labels
Children with Autism 
Disorders, No. (%)
Univariate Multivariate
OR (95% CI) P Value OR (95% CI) P Value
Clinical 
Syndrome 
Scales
Anxiety 
No 33 (0.1) Baseline 
At risk 0 — — — —
Yes 1 (0.4) 3.13 (0.43–22.96) 0.26 1.13 (.07–18.59) .932
Somatoform 
No 32 (0.1) Baseline 
At risk 2 (0.5) 3.89 (0.93–16.29) 0.063 1.62 (.27–9.68) .597
Yes 0 — — — —
Bipolar spectrum 
No 34 (0.1) Baseline 
At risk 0 — — — —
Yes 0 — — — —
Persistent Depression
No 29 (0.1) Baseline 
At risk 3 (0.6) 5.12 (1.55–16.85) 0.007 5.65 (1.61–19.85) .007
Yes 2 (0.4) 3.35 (0.80–14.09) 0.098 3.58 (.55–23.36) .182
Alcohol dependence 
No 34 (0.1) Baseline 
At risk 0 — — — —
Yes — — — — —
Drug dependence 
No 34 (0.1) Baseline 
At risk 0 — — — —
Yes 0 — — — —
Posttraumatic stress 
disorder
No 33 (0.1) Baseline 
At risk 0 — —
Yes 1 (1.2) 10.14 (1.37–75.03) 0.023 4.27 (.24–75.29) .321
Severe 
Clinical 
Syndrome 
scales
Schizophrenic 
Spectrum
No 33 (0.1) Baseline 
At risk 1 (0.5) 3.88 (0.53–28.46) 0.18 1.47 (.13–16.60) .756
Yes 0 — — — —
Major Depression
No 34 (0.1) Baseline 
At risk 0 — — — —
Yes 0 — — — —
Delusional Disorder
No 34 (0.1) Baseline 
At risk 0 — — — —
Yes 0 — — — —
                                                                                                     Arch Iran Med, Volume 22, Issue 10, October 2019 553
Prevalence, Comorbidities and Maternal Psychopathology of ASD
Ethical Statement
The Ethics Committee Board of the National Institute for Medical 
Research Development (NIMAD) has approved this study (the ethics 
code: IR.NIMAD.REC.1395.001).
Funding
The study was supported by grant 940906 from the National Institute 
for Medical Research Development (NIMAD).
Role of the Funder/Sponsor
The sponsors had no additional role in the design and conduct of the 
study; collection, management, analysis, and interpretation of the data; 
and preparation, review, or approval of the manuscript; and decision to 
submit the manuscript for publication.
Acknowledgments
First of all, thanks to the participants and their families. Then, thanks 
to the head, staff and the Neuroscience committee of the National 
Institute for Medical Research Development (NIMAD) that financially 
supported this study with grant number 940906. Especially, many 
thanks to Dr. Bita Mesgarpour and Dr. Sofia Esalatmanesh.
References 
1. Association AP. Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5®). USA: American Psychiatric Pub; 2013.
2. Xu G, Strathearn L, Liu B, Bao W. Prevalence of autism spectrum 
disorder among US children and adolescents, 2014-2016. JAMA. 
2018;319(1):81-2. doi: 10.1001/jama.2017.17812.
3. Ghanizadeh A. A preliminary study on screening prevalence of 
pervasive developmental disorder in schoolchildren in Iran. J 
Autism Dev Disord. 2008;38(4):759-63. doi: 10.1007/s10803-
007-0445-6.
4. Samadi SA, Mahmoodizadeh A, McConkey R. A national study 
of the prevalence of autism among five-year-old children in Iran. 
Autism. 2012;16(1):5-14. doi: 10.1177/1362361311407091. 
5. van Steensel FJA, Bögels SM, de Bruin EI. Psychiatric comorbidity 
in children with autism spectrum disorders: a comparison with 
children with ADHD. J Child Fam Stud. 2013;22(3):368-76. doi: 
10.1007/s10826-012-9587-z
6. Mazzone L, Ruta L, Reale L. Psychiatric comorbidities in Asperger 
syndrome and high functioning autism: diagnostic challenges. 
Ann Gen Psychiatry. 2012;11(1):16. doi: 10.1186/1744-859X-
11-16.
7. De Micheli AI, Faggioli R, Boso M, Broglia D., Orsi P., De Vidovich 
G, et al. Comorbid psychiatric symptoms in high-functioning 
autism: A clinical study. J Psychopathol (Italy). 2012;18(4):352-
358.
8. Moseley DS, Tonge BJ, Brereton AV, Einfeld SL. Psychiatric 
comorbidity in adolescents and young adults with autism. J Ment 
Health Res Intellect Disabil. 2011;4(4):229-43.
9. Chiang HL, Gau SSF. Comorbid psychiatric conditions as 
mediators to predict later social adjustment in youths with autism 
spectrum disorder. J Child Psychol Psychiatry. 2016;57(1):103-
111. doi: 10.1111/jcpp.12450.
10. Stadnick N, Chlebowski C, Baker-Ericzén M, Dyson M, Garland A, 
Brookman-Frazee L. Psychiatric comorbidity in autism spectrum 
disorder: Correspondence between mental health clinician report 
and structured parent interview. Autism. 2017;21(7):841-51. doi: 
10.1177/1362361316654083. 
11. Supekar K, Iyer T, Menon V. The influence of sex and age on 
prevalence rates of comorbid conditions in autism. Autism Res. 
2017;10(5):778-89. doi: 10.1002/aur.1741.
12. Strasser L, Downes M, Kung J, Cross JH, De Haan M. Prevalence 
and risk factors for autism spectrum disorder in epilepsy: a 
systematic review and meta-analysis. Dev Med Child Neurol. 
2018;60(1):19-29. doi: 10.1111/dmcn.13598.
13. Amiet C, Gourfinkel-An I, Bouzamondo A, Tordjman S, 
Baulac M, Lechat P, et al. Epilepsy in autism is associated 
with intellectual disability and gender: evidence from a meta-
analysis. Biol Psychiatry. 2008;64(7):577-82. doi: 10.1016/j.
biopsych.2008.04.030.
14. Memari A, Ziaee V, Mirfazeli F, Kordi R. Investigation of autism 
comorbidities and associations in a school-based community 
sample. J Child Adolesc Psychiatr Nurs. 2012;25(2):84-90. doi: 
10.1111/j.1744-6171.2012.00325.x.
15. Mohammadi MR, Zarafshan H, Ghasempour S. Broader autism 
phenotype in Iranian parents of children with autism spectrum 
disorders vs. normal children. Iran J Psychiatry. 2012;7(4):157-63.
16. Yirmiya N, Shaked M. Psychiatric disorders in parents of 
children with autism: a meta-analysis. J Child Psychol Psychiatry. 
2005;46(1):69-83. doi: 10.1111/j.1469-7610.2004.00334.x
17. Mouridsen SE, Rich B, Isager T, Nedergaard NJ. Psychiatric 
disorders in the parents of individuals with infantile autism: a 
case-control study. Psychopathology. 2007;40(3):166-71. doi 
10.1159/000100006
18. Jokiranta E, Brown AS, Heinimaa M, Cheslack-Postava K, 
Suominen A, Sourander A. Parental psychiatric disorders and 
autism spectrum disorders. Psychiatry Res. 2013;207(3):203-11. 
doi: 10.1016/j.psychres.2013.01.005. 
19. Mohammadi MR, Ahmadi N, Khaleghi A, Mostafavi SA, Kamali 
K, Rahgozar M, et al. Prevalence and Correlates of Psychiatric 
Disorders in a National Survey of Iranian Children and 
Adolescents. Iran J Psychiatry. 2019;14(1):1-15.
20. Mohammadi MR, Ahmadi N, Kamali K, Khaleghi A, Ahmadi A. 
Epidemiology of Psychiatric Disorders in Iranian Children and 
Adolescents (IRCAP) and Its Relationship with Social Capital, Life 
Style and Parents’ Personality Disorders: Study Protocol. Iran J 
Psychiatry. 2017;12(1):66-72.
21. Jarbin H, Andersson M, Råstam M, Ivarsson T. Predictive 
validity of the K-SADS-PL 2009 version in school-aged and 
adolescent outpatients. Nord J Psychiatry. 2017;71(4):270-6. doi: 
10.1080/08039488.2016.1276622.
22. Ghanizadeh A, Mohammadi MR, Yazdanshenas A. Psychometric 
properties of the Farsi translation of the kiddie schedule for 
affective disorders and schizophrenia-present and lifetime 
version. BMC Psychiatry. 2006;6:10. doi 10.1186/1471-244X-6-
10
23. Millon T, Grossman S. MCMI-IV: Millon Clinical Multiaxial 
Inventory Manual. J Pers Assess. 2015;97(6):541-9. doi: 
10.1080/00223891.2015.1055753.
24. Elsabbagh M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcín C, et al. 
Global prevalence of autism and other pervasive developmental 
disorders. Autism Res. 2012;5(3):160-79. doi: 10.1002/aur.239. 
25. Thomas S, Hovinga ME, Rai D, Lee BK. Brief Report: Prevalence 
of Co-occurring Epilepsy and Autism Spectrum Disorder: The U.S. 
National Survey of Children’s Health 2011–2012. J Autism Dev 
Disord. 2017;47(1):224-9. doi: 10.1007/s10803-016-2938-7.
26. Niemczyk J, Wagner C, von Gontard A. Incontinence in autism 
spectrum disorder: a systematic review. Eur Child Adolesc 
Psychiatry. 2018;27(12):1523-37. doi: 10.1007/s00787-017-
1062-3. 
27. Houghton R, Ong RC, Bolognani F. Psychiatric comorbidities and 
use of psychotropic medications in people with autism spectrum 
disorder in the United States. Autism Res. 2017;10(12):2037-47. 
doi: 10.1002/aur.1848. 
28. Daniels JL, Forssen U, Hultman CM, Cnattingius S, Savitz DA, 
Feychting M, et al. Parental psychiatric disorders associated 
with autism spectrum disorders in the offspring. Pediatrics. 
2008;121(5):e1357-62. doi: 10.1542/peds.2007-2296.
29. Greenland S, Mansournia MA, Altman DG. Sparse data bias: 
a problem hiding in plain sight. BMJ. 2016;352:i1981. doi: 
10.1136/bmj.i1981. 
                    © 2019 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.
org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
